Approval for an Additional Pediatric Hepatic Encephalopathy Indication for L-105
A product-specific initiative to complete a Phase II/III trial in pediatric hepatic encephalopathy for L-105, file for an additional indication, and obtain approval for a partial change to the product's manufacturing and marketing authorization.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.